Abstract
By the mid '90s, transcatheter ablation of atrial fibrillation (AF) has undergone a strong and impetuous advance, becoming a well known and worldwide accepted therapeutic procedure offered to patients with different types of AF and clinical features. The present paper aims to describe the main concepts behind the evolution of transcatheter ablation of AF, to review clinical indications, and to analyze current outcomes in terms of efficacy and safety.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
